Investor mix
7 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 2 | 29% |
| Other / undisclosed | 5 | 71% |
Research based pharma company focused on developing treatment for spinal muscular atrophy
7 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 2 | 29% |
| Other / undisclosed | 5 | 71% |